PalinGen® Membrane
Wound Care, Orthopedic Repair
ApprovedActive
Key Facts
About Amnio Technology
Amnio Technology, founded in 2008 and headquartered in Phoenix, Arizona, is a private company commercializing a portfolio of amniotic allograft products under the PalinGen® brand. Its core differentiator is a proprietary manufacturing process (Advantec©) that removes the chorion layer, which it claims reduces immunogenic risk. The company is in the commercial stage, selling its products to hospitals and clinics nationwide for wound care and orthopedic indications, with a reported track record of zero adverse events and over 0K+ products implanted.
View full company profileTherapeutic Areas
Other Wound Care, Orthopedic Repair Drugs
| Drug | Company | Phase |
|---|---|---|
| PalinGen® Hydromembrane | Amnio Technology | Approved |
| PalinGen® XPlus Membrane | Amnio Technology | Approved |
| PalinGen® XPlus Hydromembrane | Amnio Technology | Approved |